Newcastle University

Laura Ternent is a Lecturer in Health Economics.  Laura has a strong academic background in both applied and methodological work.  Research interests include economic evaluations alongside RCTs, economic modelling and health outcome valuation.  Laura has worked in a number of academic research institutions including the University of Wales, Bangor and University of Aberdeen.

• Ternent L, McNamee P, Newlands D, Belemsaga D, Gbangou A, Cross S. Willingness to pay for maternal health outcomes. Applied Health Economics and Health Policy 2010, 8(2), 99-109.
• Robertson C, Boachie C, Dixon M, Fraser C, Hernandez R, Heys S, Jack W, Kerr G, Ragupathy S, Lawrence G, MacLennan G, Maxwell A, McGregor J, Mowatt G, Pinder S, Ternent L, Thomas R, Vale L, Wilson R, Zhu S, Gilbert F. The clinical effectiveness and cost-effectiveness of different surveillance mammography regimes after the treatment of primary breast cancer. Health Technology Assessment 2011, 15(34), 322pp.
• McNamee P, Ternent L, Gbangou A, Newlands D. A game of two halves?: Incentive incompatibility, starting point bias and the bidding game contingent valuation method. Health Economics 2010, 19(1), 75-87.
• Imamura M, Abrams P, Bain C, Buckley B, Cardozo L, Cody J, Cook J, Eustice S, Glazener C, Grant A, Hay-Smith J, Hislop J, Jenkinson D, Kilonzo M, Nabi G, N'Dow J, Pickard R, Ternent L, Wallace S, Wardle J, Zhu S, Vale L. Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technology Assessment 2010, 14(40), 1-188, iii-iv.
• McNamee P, Ternent L, Hussein J. Barriers in accessing maternal health care: evidence from low and middle income countries. Expert Review of Pharmacoeconomics & Outcomes Research 2009, 9(1), 41-48.
• Ternent L, Vale L, Buckley B, Glazener C. Measuring outcomes of importance to women with stress urinary incontinence. British Journal of Obstetrics and Gynaecology 2009, 116(5), 719-725.
• Mowatt G, Boachie C, Crowther M, Fraser C, Hernandez R, Jia X, Ternent L. Romiplostim for the treatment of chronic immune or idiopathic thrombocytopenic purpura (ITP): A Single Technology Appraisal. Health Technology Assessment 2009, 13(s2), 63-68.
• Brittenden J, Burr J, Campbell M, Chetter I, Cotton S, Earnshaw J, Francis J, Gough M, McDonald A, McPherson G, Ramsay C, Ternent L, Vale L. [Protocol Review] The CLASS Study: Comparison of LAser, Surgery and foam Sclerotherapy as a treatment for varicose veins. The Lancet Publishing Group, 2009. Available at: http://www.thelancet.com/protocol-reviews/09PRT-2275.
• Newlands D, Belemsaga D, Ternent L, Hounton S. Assessing the costs and cost-effectiveness of a Skilled Care Initiative in rural Burkina Faso. Tropical Medicine and International Health 2008, 13, 61-67.
• Ternent L, Vale L, Boachie C, Burr JM, Lois N, Full-Thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS) Group. Cost-effectiveness of internal limiting membrane peeling versus no peeling for patients with an idiopathic full-thickness macular hole: results from a randomised controlled trial. British Journal of Opthalmology 2012, 96(3), 438-443.
• Lois N, Burr J, Norrie J, Vale L, Cook J, McDonald A, Boachie C, Ternent L, McPherson G. Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial. Investigative Ophthalmology & Visual Science 2011, 52(1), 35-42.